These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 9301677

  • 1. Alkyl-substituted amino acid amides and analogous di- and triamines: new non-peptide G protein activators.
    Leschke C, Storm R, Breitweg-Lehmann E, Exner T, Nürnberg B, Schunack W.
    J Med Chem; 1997 Sep 12; 40(19):3130-9. PubMed ID: 9301677
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. G protein activation by human dopamine D3 receptors in high-expressing Chinese hamster ovary cells: A guanosine-5'-O-(3-[35S]thio)- triphosphate binding and antibody study.
    Newman-Tancredi A, Cussac D, Audinot V, Pasteau V, Gavaudan S, Millan MJ.
    Mol Pharmacol; 1999 Mar 12; 55(3):564-74. PubMed ID: 10051542
    [Abstract] [Full Text] [Related]

  • 7. Comparative analysis of the efficacy of A1 adenosine receptor activation of Gi/o alpha G proteins following coexpression of receptor and G protein and expression of A1 adenosine receptor-Gi/o alpha fusion proteins.
    Wise A, Sheehan M, Rees S, Lee M, Milligan G.
    Biochemistry; 1999 Feb 23; 38(8):2272-8. PubMed ID: 10029519
    [Abstract] [Full Text] [Related]

  • 8. Structural requirements for G(o) activation by receptor-derived peptides: activation and modulation domains of the alpha 2-adrenergic receptor i3c region.
    Wade SM, Scribner MK, Dalman HM, Taylor JM, Neubig RR.
    Mol Pharmacol; 1996 Aug 23; 50(2):351-8. PubMed ID: 8700143
    [Abstract] [Full Text] [Related]

  • 9. Action of brefeldin A blocked by activation of a pertussis-toxin-sensitive G protein.
    Ktistakis NT, Linder ME, Roth MG.
    Nature; 1992 Mar 26; 356(6367):344-6. PubMed ID: 1549178
    [Abstract] [Full Text] [Related]

  • 10. Activation of constitutive 5-hydroxytryptamine(1B) receptor by a series of mutations in the BBXXB motif: positioning of the third intracellular loop distal junction and its G(o)alpha protein interactions.
    Pauwels PJ, Gouble A, Wurch T.
    Biochem J; 1999 Oct 15; 343 Pt 2(Pt 2):435-42. PubMed ID: 10510311
    [Abstract] [Full Text] [Related]

  • 11. Synthetic lipopeptides activate nucleoside diphosphate kinase in HL-60 membranes.
    Klinker JF, Seifert R.
    Biochem Biophys Res Commun; 1995 Apr 17; 209(2):575-81. PubMed ID: 7733927
    [Abstract] [Full Text] [Related]

  • 12. Hydrophobicity of residue351 of the G protein Gi1 alpha determines the extent of activation by the alpha 2A-adrenoceptor.
    Bahia DS, Wise A, Fanelli F, Lee M, Rees S, Milligan G.
    Biochemistry; 1998 Aug 18; 37(33):11555-62. PubMed ID: 9708991
    [Abstract] [Full Text] [Related]

  • 13. Functional differences between full and partial agonists: evidence for ligand-specific receptor conformations.
    Seifert R, Wenzel-Seifert K, Gether U, Kobilka BK.
    J Pharmacol Exp Ther; 2001 Jun 18; 297(3):1218-26. PubMed ID: 11356949
    [Abstract] [Full Text] [Related]

  • 14. Thrombin receptor activation by thrombin and receptor-derived peptides in platelet and CHRF-288 cell membranes: receptor-stimulated GTPase and evaluation of agonists and partial agonists.
    Seiler SM, Peluso M, Tuttle JG, Pryor K, Klimas C, Matsueda GR, Bernatowicz MS.
    Mol Pharmacol; 1996 Jan 18; 49(1):190-7. PubMed ID: 8569706
    [Abstract] [Full Text] [Related]

  • 15. Role of isoprenoid metabolism in chemotactic peptide receptor-mediated G protein activation.
    McLeish KR, Lederer ED, Klein JB.
    Biochem Biophys Res Commun; 1993 Dec 15; 197(2):763-70. PubMed ID: 8267613
    [Abstract] [Full Text] [Related]

  • 16. Pharmacological characterization of the human melatonin Mel1a receptor following stable transfection into NIH3T3 cells.
    Nonno R, Lucini V, Pannacci M, Mazzucchelli C, Angeloni D, Fraschini F, Stankov BM.
    Br J Pharmacol; 1998 Jun 15; 124(3):485-92. PubMed ID: 9647472
    [Abstract] [Full Text] [Related]

  • 17. Differential G-protein activation by alkaloid and peptide opioid agonists in the human neuroblastoma cell line SK-N-BE.
    Allouche S, Polastron J, Hasbi A, Homburger V, Jauzac P.
    Biochem J; 1999 Aug 15; 342 ( Pt 1)(Pt 1):71-8. PubMed ID: 10432302
    [Abstract] [Full Text] [Related]

  • 18. Regulation of Gi and Go by mastoparan, related amphiphilic peptides, and hydrophobic amines. Mechanism and structural determinants of activity.
    Higashijima T, Burnier J, Ross EM.
    J Biol Chem; 1990 Aug 25; 265(24):14176-86. PubMed ID: 2117607
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. G alpha(i) and G alpha(o) are target proteins of reactive oxygen species.
    Nishida M, Maruyama Y, Tanaka R, Kontani K, Nagao T, Kurose H.
    Nature; 2000 Nov 23; 408(6811):492-5. PubMed ID: 11100733
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.